| 000 | 01407 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250510205415.0 | ||
| 264 | 0 | _c19790716 | |
| 008 | 197907s 0 0 eng d | ||
| 022 | _a0003-4819 | ||
| 024 | 7 |
_a10.7326/0003-4819-90-2-219 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalne, D B | |
| 245 | 0 | 0 |
_aAdvances in the neuropharmacology of Parkinsonism. _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cFeb 1979 |
||
| 300 |
_a219-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xmetabolism |
| 650 | 0 | 4 |
_aCatecholamines _xmetabolism |
| 650 | 0 | 4 |
_aCerebral Cortex _xphysiopathology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aNerve Endings _xmetabolism |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xmetabolism |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 |
_aSynapses _xdrug effects |
| 700 | 1 | _aKebabian, J | |
| 700 | 1 | _aSilbergeld, E | |
| 700 | 1 | _aEvarts, E | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 90 _gno. 2 _gp. 219-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-90-2-219 _zAvailable from publisher's website |
| 999 |
_c34993 _d34993 |
||